QVT Financial’s Clovis Oncology, Inc. CLVS Stock Holding History

QVT Financial’s Portfolio CLVS Stock Details CLVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-3,525,000	Closed	-$4.2M	–	62
2022 Q3	$4.2M	Buy	3,525,000 +1,425,000	+68%	+$2.22M	0.29%	37
2022 Q2	$3.78M	Buy	2,100,000 +1,595,000	+316%	+$2.35M	0.24%	42
2022 Q1	$1.02M	Hold	505,000	–	–	0.04%	57
2021 Q4	$1.37M	Buy	+505,000	New	+$1.87M	0.05%	52
2014 Q3	–	Sell	-209,735	Closed	-$8.69M	–	89
2014 Q2	$8.69M	Sell	209,735 -180,000	-46%	-$9.27M	0.47%	61
2014 Q1	$27M	Sell	389,735 -9,100	-2%	-$668K	1.55%	22
2013 Q4	$24M	Buy	398,835 +53,875	+16%	+$2.93M	1.41%	22
2013 Q3	$21M	Sell	344,960 -272,718	-44%	-$19.3M	1.43%	26
2013 Q2	$41.4M	Buy	+617,678	New	+$27.8M	2.78%	10

Other funds holding CLVS

IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

CAS

Coppell Advisory Solutions Coppell, Texas $170M AUM 13.42% 1-Year Est. Return

CASC

Coppell Advisory Solutions Corp Coppell, Texas $531M AUM

STB

S&T Bank Indiana, Pennsylvania $268M AUM 39.92% 1-Year Est. Return

MCM

MAI Capital Management Independence, Ohio $17.7B AUM 18.87% 1-Year Est. Return

Wedbush Securities Los Angeles, California $3.43B AUM 24.13% 1-Year Est. Return

FFWM

Future Financial Wealth Management Cincinnati, Ohio $155M AUM 13% 1-Year Est. Return

NFSG

Newbridge Financial Services Group Boca Raton, Florida $608M AUM 31.28% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

QVT Financial's CLVS Position: Q4 2022 in Review

QVT Financial sold out of Clovis Oncology, Inc. (CLVS) in Q4 2022, closing a stake of 3,525,000 shares — an estimated $4.2M sold.

QVT Financial first reported a position in CLVS in Q2 2013 and held it in 9 quarters. The position peaked at $41.4M in Q2 2013. 15 funds tracked by Wall St. Rank hold CLVS as of Q4 2022.

QVT Financial reported no remaining Clovis Oncology, Inc. position as of Q4 2022 after selling out during the quarter.
QVT Financial sold 3,525,000 Clovis Oncology, Inc. shares in Q4 2022, an estimated $4.2M.
QVT Financial first reported a position in Clovis Oncology, Inc. in Q2 2013 and held it in 9 quarters.
QVT Financial's Clovis Oncology, Inc. position peaked at $41.4M in Q2 2013.
15 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q4 2022.

Based on QVT Financial's 13F filing for Q4 2022, filed 14 Feb 2023.